Obesity is an important component of metabolic syndrome. In this study, we aim to research the effect of laparoscopic sleeve gastrectomy (LSG) on metabolic syndrome.
Methods:
A total of 164 patients who had undergone LSG between January 2013 and August 2016 were included in the study. Data collected from preoperative examinations and follow-ups until the 12th month postoperation were retrospectively analyzed.
Results:
A total of 86.6% of patients were female and 13.4% were male. The average age was 36.6 years and average body mass index was 45.5 kg/m2. Excess weight loss was 48.5% in month 3, 67% in month 6, and 83.7% in month 12. The number of patients diagnosed with metabolic syndrome preoperatively was 118; this number dropped to 29 by the 6th month and to 11 by the 12th month.
Conclusions:
LSG is a very effective procedure for treating metabolic syndrome, which is considered an important cause of mortality and morbidity.
Get full access to this article
View all access options for this article.
References
1.
VisscherTL, SeidellJC. The public health impact of obesity. Annu Rev Public Health, 2001; 22:355–375.
2.
OgdenCL, CarrollMD, CurtinLR, McDowellMA, TabakCJ, FlegalKM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA, 2006; 295:1549–1555.
GagnerM, DeitelM, EricksonAL, CrosbyRD. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg, 2013; 23:2013–2017.
GluckB, MovitzB, JansmaS, GluckJ, LaskowskiK. Laparoscopic sleeve gastrectomy is a safe and effective bariatric procedure for the lower BMI (35.0–43.0 kg/m2) population. Obes Surg, 2011; 21:1168–1171.
10.
BozaC, SalinasJ, SalgadoN, PérezG, RaddatzA, FunkeR, et al.Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1,000 cases and 3-year follow-up. Obes Surg, 2012; 22:866–871.
11.
HoyuelaC. Five-year outcomes of laparoscopic sleeve gastrectomy as a primary procedure for morbid obesity: a prospective study. World Journal of Gastrointestinal Surgery, 2017; 9:109–117.
12.
JonathanD, MichelleA, KaraJ, ShanuN. Is laparoscopic sleeve gastrectomy a lower risk bariatric procedure compared with laparoscopic Roux-en-Y gastric bypass? A meta-analysis. Am J Surg, 2014; 208:903–910.
13.
StacyA, KothariS, SudanR, WilliamsB, EnglishWJ, BrengmanM, et al.Systematic review on reoperative bariatric surgery. Surgery for Obesity and Related Diseases, 2014; 10:952–972.
14.
GolombI, Ben DavidM, GlassA, KolitzT, KeidarA. Long-term metabolic effects of laparoscopic sleeve gastrectomy. JAMA Surg, 2015; 150:1051–1057.
15.
SamehE, HossamE, KhaledE, EmadA. Laparoscopic sleeve gastrectomy then and now: an updated systematic review of the progress and short-term outcomes over the last 5 years. Surg Laparosc Endosc Percutan Tech, 2017; 27:307–317.
16.
PatrickN, MariusN, ImaneE, ThierryM, MichelG. What are the long-term results 8 years after sleeve gastrectomy?. Surg Obes Relat Dis, 2017; 13:1110–1115.
17.
KowalewskiP, OlszewskiR, WalędziakMS, JanikMR, KwiatkowskiA, Gałązka-ŚwiderekN, et al.Long-term outcomes of laparoscopic sleeve gastrectomy-a single-center, retrospective study. Obes Surg, 2018; 28:130–134.
18.
SpivakH, SakranN, DickerD, RubinM, RazI, ShohatT, et al.Different effects of bariatric surgical procedures on dyslipidemia: a registry-based analysis. Surg Obes Relat Dis, 2017; 13:1189–1194.
19.
ClimentE, BenaigesD, Pedro-BotetJ, Flores-Le RouxJA, RamónJM, et al.Atherogenic dyslipidemia remission 1 year after bariatric surgery. Obes Surg, 2017; 27:1548–1553.
20.
CătoiAF, PârvuA, MironiucA, GaleaRF, MureşanA, BidianC, et al.Effects of sleeve gastrectomy on insulin resistance. Clujul Med, 2016; 89:267–272.
21.
RizzelloM, AbbatiniF, CasellaG, AlessandriG, FantiniA, LeonettiF, et al.Early ameliyat sonrasıerative insulin-resistance changes after sleeve gastrectomy. Obes Surg, 2010; 20:50–55.
22.
MeydanC, GoldsteinN, Weiss-ShwartzE, LederfineD, GoiteinD, RubinM, et al.Immediate metabolic response following sleeve gastrectomy in obese diabetics. Obes Surg, 2015; 25:2023–2029.
23.
EickhoffH, GuimarãesA, LouroTM, SeiçaRM, CastroE, SousaF. Insulin resistance and beta cell function before and after sleeve gastrectomy in obese patients with impaired fasting glucose or type 2 diabetes. Surg Endosc, 2015; 29:438–443.
24.
BarzinM, MotamediMAK, SerahatiS, KhalajA, ArianP, ValizadehM, et al.Comparison of the effect of gastric bypass and sleeve gastrectomy on metabolic syndrome and its components in a cohort: Tehran Obesity Treatment Study (TOTS). Obes Surg, 2017; 27:1697–1704.
25.
MenquerRK, WestonAC, SchmidH. Evaluation of metabolic syndrome in morbidly obese patients submitted to laparoscopic bariatric surgery: comparison of the results between roux-en-Y gastric bypass and sleevegastrectomy. Obes Surg, 2017; 27:1719–1723.
26.
SethiP, ThillaiM, NainPS, AhujaA, VayothSO, KhuranaP. Effects of laparoscopic sleeve gastrectomy on central obesity and metabolic syndrome in indian adults—a prospective study. J Clin Diagn Res, 2017; 11:PC01–PC04.
27.
ShabbirA, DarganD. The success of sleeve gastrectomy in the management of metabolic syndrome and obesity. J Biomed Res, 2015; 29:93–97.
